-+ 0.00%
-+ 0.00%
-+ 0.00%

AURA BIOSCIENCES ANNOUNCES ENROLLMENT COMPLETION IN PHASE 3 COMPASS TRIAL OF BEL-SAR IN EARLY CHOROIDAL MELANOMA

Reuters·06/01/2026 12:00:04

Please log in to view news